Zacks Research Has Negative View of AstraZeneca Q1 Earnings
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Zacks Research reduced their Q1 2026 earnings estimates for AstraZeneca in a research report issued on Wednesday, April 9th. Zacks Research analyst R. Department now expects that the company will post earnings of $1.15 per share for the quarter, down from their prior estimate of […]
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Zacks Research reduced their Q1 2026 earnings estimates for AstraZeneca in a research report issued on Wednesday, April 9th. Zacks Research analyst R. Department now expects that the company will post earnings of $1.15 per share for the quarter, down from their prior estimate of […]